Characterization of a delta electroencephalogram-sleep-inducing peptide DSIP: a review of its functional significance
Avoid areas with scars, stretch marks, bruises, or moles
Theres something incredibly rewarding about seeing how your workout results look on your newly contoured body
That sounds alarming until you put it in context
monitoring progress and response to treatment over time (including using IoT-connected devices)
Key Takeaways: Semaglutide is the active ingredient in both Ozempic and Wegovy, working by mimicking GLP-1 to reduce appetite and improve blood sugar control. Wegovy (higher-dose semaglutide) is FDA-approved for weight loss, while Ozempic is primarily approved for type 2 diabetes but often used off-label. Clinical trials show semaglutide can lead to ~15% body weight loss over ~68 weeks when combined with lifestyle changes. Ozempic typically produces slightly lower average weight loss due to its lower maximum dose, though results can still be significant. Gradual tapering off semaglutide, combined with lifestyle support, may help reduce weight regain after stopping treatment. Long-term success depends on pairing medication with nutrition, physical activity, and ongoing medical guidance. Understanding the Basics Semaglutide is the active drug found in both Ozempic and Wegovy
